Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cross-reactivity

Cross-reactivity

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Make science evolve into a One Health approach to improve health and security: a white paper.

One health outlook·2020

Same author

COVID-19: losing battles or winning the war?

One health outlook·2020

Same author

Human Paramyxovirus Infections Induce T Cells That Cross-React with Zoonotic Henipaviruses.

mBio·2020

Same author

Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection.

Nature communications·2020

Same author

A human monoclonal antibody blocking SARS-CoV-2 infection.

Nature communications·2020

Same author

Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines.

Vaccine·2019

Search research articles

Related Experiment Video

Updated: Apr 30, 2026

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

Neutralizing the MERS coronavirus threat.

Bart L Haagmans¹, Albert D M E Osterhaus

¹Department of Viroscience, Erasmus Medical Center, 3000 CA Rotterdam, the Netherlands.

Science Translational Medicine

|May 9, 2014

Summary

Human neutralizing monoclonal antibodies show promise for preventing and treating Middle East respiratory syndrome coronavirus (MERS-CoV) infections. These antibodies offer potential prophylactic and therapeutic strategies against MERS-CoV. Keywords: monoclonal antibodies, MERS-CoV, prevention, treatment.

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

Related Experiment Videos

Last Updated: Apr 30, 2026

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

Area of Science:

Virology
Immunology
Infectious Diseases

Background:

Middle East respiratory syndrome coronavirus (MERS-CoV) poses a significant public health threat.
Effective prophylactic and therapeutic interventions for MERS-CoV infection are urgently needed.

Purpose of the Study:

To evaluate human neutralizing monoclonal antibodies as potential candidates for MERS-CoV intervention.
To explore the efficacy of monoclonal antibodies in combating MERS-CoV.

Main Methods:

The study focuses on the development and assessment of human neutralizing monoclonal antibodies.
Investigational approaches to antibody-based MERS-CoV therapies are central.

Main Results:

Human neutralizing monoclonal antibodies demonstrate potential for MERS-CoV.
Antibody-based strategies are being explored for prophylactic and therapeutic use.

Conclusions:

Human neutralizing monoclonal antibodies represent a promising avenue for MERS-CoV control.
Further research into these antibodies could lead to novel interventions against MERS-CoV.